Search

Supply of Medicine and Medical / Surgical equipments : Lipoomal form of Ampotericin B 50mg vial\nLiposomal form of Amphotericin B 50 mg vial\nA sterile, pyrogen free, lyophilized powder for\ndispersion for infusion.\nEach vial should contain as active ingredient 50 mg\n(50,000 units) of Amphotericin B intercalated in\nliposomes. After reconstitution in sterile water for\ninjection, the concentrated solution should contain\n4mg/ml of Amphotericine B.\nEach vial should be packed individually in a carton\nwith a product information leaflet including details\non administration and a device for filtration with the\nmean pore diameter of the filter not less than 1.0\nmicron.\nPrequalification\nThe manufacturer should have the following\ndocuments\n1) Certificate of registration in\na. the country of manufacturer\nb. Sri Lanka\nc. other countries where the product is registered\n2) Evidence of current use in the country of\nmanufacture\n3) Evidence of current use in reference countries\nnamely USA, UK and Ireland. Australia, Canada,\nGermany, Japan, Italy\n4) Evidence of WHO pre-qualification is preferable etc ...

spn

General Information

   Oct 16, 2024
   English
   International procurement
   published: Oct 16, 2024

Original Text

SR No. Item Description/ Specification Quantity Delivery 00107403 Lipoomal form of Ampotericin B 50mg vial\nLiposomal form of Amphotericin B 50 mg vial\nA sterile, pyrogen free, lyophilized powder for\ndispersion for infusion.\nEach vial should contain as active ingredient 50 mg\n(50,000 units) of Amphotericin B intercalated in\nliposomes...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.